VRAX
Virax Biolabs Group Limited Ordinary SharesRecent alerts on VRAX
All signals →
SEC filing
VRAX Reports 88% Specificity, 92% PPV for ViraxImmune™ in Long COVID Trial, Targets $1.4B+ US Testing Market
7d ago
Scanner
Large up move: 53.1% (3.0x normal daily movement)
14d ago
SEC filing
VRAX Announces $6.4M Cash Position, $25B PAIS Market, ViraxImmune™ LDT Pathway, ISO 13485 Certified, Debt-Free, $2.6M Valuation Gap
49d ago
SEC filing
VRAX Reports No Revenue, $0 Net Income, Files 6-K for April 2026
52d ago
News
Apollo Seeks to Reassure Clients About Executives’ Epstein Ties
103d ago
News
Cisco CEO Robbins Outlines AI Platform Strategy Across Networking and Security
104d ago
News
Apollo Global Management CFO Sees Higher Rates Ahead as Origination Hits $300B, FRE Jumps 23%
104d ago
News
Apollo Global Management Touts $40T Private Credit Opportunity, AI Financing and Fund XI at BofA Conference
106d ago
Scanner
Unusual volume (2.2x average)
117d ago
Get push alerts for VRAX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS